Release date: 2026-01-07 17:16:28 Recommended: 207
Ixazomib is a targeted, reversible proteasome inhibitor that has been approved for use in combination with lenalidomide and dexamethasone for the treatment of relapsed multiple myeloma.
This product is Ixazomib manufactured by Lucius Pharmaceuticals Co., Ltd., with a standard specification of 4 mg per capsule and 30 capsules per box. The drug price is subject to fluctuations due to factors such as procurement channels, regional medical insurance policies, market supply and demand, and specific order quantities. If you have purchase or consultation needs, please visit the website homepage and obtain the latest information and professional guidance through the customer service contact information.
1. Ixazomib is an oral capsule. It should usually be taken on an empty stomach with warm water, at least 1 hour before or 2 hours after a meal. A treatment cycle is 28 days, and the drug should be administered on Days 1, 8, and 15. Try to take the medication at the same fixed time every day. Please carefully follow the instructions on the prescription label. If you have any questions, consult your doctor or pharmacist. Strictly take the medicine as directed by your doctor. Do not increase or decrease the dosage or change the frequency of administration on your own.
2. Do not take Ixazomib and dexamethasone at the same time, because dexamethasone needs to be taken with meals.
3. Swallow the capsule whole. Do not break, chew, or crush it.
4. Handle the capsules with caution. Avoid contact of broken or crushed capsules with the skin, eyes, mouth, or nasal cavity. If contact occurs, immediately wash the affected skin area with soap and water, or rinse the eyes with clean water.
5. If vomiting occurs after taking the medicine, do not take a supplementary dose. Take the regular dose on the next scheduled dosing day as originally planned.
6. Depending on the side effects you experience, your doctor may need to temporarily or permanently discontinue treatment, or adjust the dosage of Ixazomib and other concomitant medications. Be sure to inform your doctor of your physical condition during treatment. Do not stop taking the medicine without your doctor's guidance.
7. If you need a copy of the drug package insert, please request it from your pharmacist or doctor.
1. Inform your doctor and pharmacist if you are allergic to Ixazomib, other medications, or any ingredients in Ixazomib capsules. You may request a list of ingredients from your pharmacist.
2. Inform your doctor and pharmacist of all prescription drugs, over-the-counter drugs, vitamins, and nutritional supplements you are taking or plan to take. Your doctor may need to adjust the dosage or closely monitor for side effects.
3. The following herbal products may interact with Ixazomib: St. John's Wort. Be sure to inform your doctor and pharmacist if you are using this herbal product before starting Ixazomib treatment. Do not start using this herbal product during Ixazomib treatment without evaluation by a medical professional.
4. Inform your doctor if you have or have ever had liver or kidney disease.
5. Inform your doctor if you are pregnant, planning to become pregnant, or planning to make your partner pregnant. Avoid pregnancy while taking Ixazomib. Effective contraceptive measures should be taken during treatment and for 90 days after the last dose. If you are male and your partner is capable of becoming pregnant, you should also use effective contraception during treatment and for 90 days after the last dose. Discuss with your doctor the contraceptive methods that are suitable for you. If you or your partner becomes pregnant while taking the medicine, contact your doctor immediately. Ixazomib may cause harm to the fetus.
6. Inform your doctor if you are breastfeeding. Breastfeeding should be discontinued while taking Ixazomib.